please explain, page-4

UK alone are stocking up on 60m doses at GBP 660m.

http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/5858430/GSK-in-line-for-1.3bn-swine-flu-booster.html

http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/5889003/Glaxo-to-have-swine-flu-vaccine-by-September.html

GSK are likely going to have to ramp up production to relatively phenomenal numbers to meet future global demand IMO.

This can only send Biota into orbit!

Next, LANI and then some.....

Does anyone know if GSK have any rights to LANI ?
Does the pharma partner in Japan (2nd largest pharma in Japan) have rights to LANI ?

Thoughts ?